ERNA vs MTCH · P/E 0.0, rev $582.0K vs P/E 13, rev $3.48B
Eterna Therapeutics Inc (ERNA) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the ERNA and MTCH stock pages for the full models.
Not investment advice.